Načítá se...

Creating an arsenal of Adeno-associated virus (AAV) gene delivery stealth vehicles

The Adeno-associated virus (AAV) gene delivery system is ushering in a new and exciting era in the United States; following the first approved gene therapy (Glybera) in Europe, the FDA has approved a second therapy, Luxturna [1]. However, challenges to this system remain. In viral gene therapy, the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS Pathog
Hlavní autoři: Smith, J. Kennon, Agbandje-McKenna, Mavis
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933702/
https://ncbi.nlm.nih.gov/pubmed/29723270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.ppat.1006929
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!